DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
82.04
+0.43 (0.53%)
Nov 17, 2026, 4:00 PM EST - Market closed

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of $30.60 billion. The enterprise value is $30.17 billion.

Market Cap30.60B
Enterprise Value 30.17B

Important Dates

The last earnings date was Thursday, October 29, 2026, after market close.

Earnings Date Oct 29, 2026
Ex-Dividend Date n/a

Share Statistics

DexCom has 372.95 million shares outstanding. The number of shares has decreased by -3.92% in one year.

Current Share Class 372.95M
Shares Outstanding 372.95M
Shares Change (YoY) -3.92%
Shares Change (QoQ) -1.69%
Owned by Insiders (%) 0.24%
Owned by Institutions (%) 102.40%
Float 371.61M

Valuation Ratios

The trailing PE ratio is 32.17 and the forward PE ratio is 27.82. DexCom's PEG ratio is 1.33.

PE Ratio 32.17
Forward PE 27.82
PS Ratio 5.99
Forward PS 5.45
PB Ratio 12.07
P/TBV Ratio 12.73
P/FCF Ratio 27.86
P/OCF Ratio 21.63
PEG Ratio 1.33
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.13, with an EV/FCF ratio of 27.47.

EV / Earnings 30.45
EV / Sales 5.91
EV / EBITDA 20.13
EV / EBIT 24.65
EV / FCF 27.47

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.55.

Current Ratio 1.74
Quick Ratio 1.34
Debt / Equity 0.55
Debt / EBITDA 0.91
Debt / FCF 1.27
Interest Coverage 91.33

Financial Efficiency

Return on equity (ROE) is 37.67% and return on invested capital (ROIC) is 45.93%.

Return on Equity (ROE) 37.67%
Return on Assets (ROA) 11.13%
Return on Invested Capital (ROIC) 45.93%
Return on Capital Employed (ROCE) 30.70%
Weighted Average Cost of Capital (WACC) 11.69%
Revenue Per Employee $459,856
Profits Per Employee $89,279
Employee Count11,100
Asset Turnover 0.74
Inventory Turnover 2.72

Taxes

In the past 12 months, DexCom has paid $271.40 million in taxes.

Income Tax 271.40M
Effective Tax Rate 21.50%

Stock Price Statistics

The stock price has increased by +41.30% in the last 52 weeks. The beta is 1.44, so DexCom's price volatility has been higher than the market average.

Beta (5Y) 1.44
52-Week Price Change +41.30%
50-Day Moving Average 84.12
200-Day Moving Average 75.17
Relative Strength Index (RSI) 48.84
Average Volume (20 Days) 5,196,842

Short Selling Information

The latest short interest is 15.93 million, so 4.27% of the outstanding shares have been sold short.

Short Interest 15.93M
Short Previous Month 15.69M
Short % of Shares Out 4.27%
Short % of Float 4.29%
Short Ratio (days to cover) 3.52

Income Statement

In the last 12 months, DexCom had revenue of $5.10 billion and earned $991.00 million in profits. Earnings per share was $2.55.

Revenue5.10B
Gross Profit 3.24B
Operating Income 1.22B
Pretax Income 1.26B
Net Income 991.00M
EBITDA 1.50B
EBIT 1.22B
Earnings Per Share (EPS) $2.55
Full Income Statement

Balance Sheet

The company has $1.82 billion in cash and $1.39 billion in debt, with a net cash position of $425.00 million or $1.14 per share.

Cash & Cash Equivalents 1.82B
Total Debt 1.39B
Net Cash 425.00M
Net Cash Per Share $1.14
Equity (Book Value) 2.54B
Book Value Per Share 6.80
Working Capital 1.66B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.41 billion and capital expenditures -$316.10 million, giving a free cash flow of $1.10 billion.

Operating Cash Flow 1.41B
Capital Expenditures -316.10M
Depreciation & Amortization 275.00M
Net Borrowing -1.21B
Free Cash Flow 1.10B
FCF Per Share $2.94
Full Cash Flow Statement

Margins

Gross margin is 63.42%, with operating and profit margins of 23.98% and 19.41%.

Gross Margin 63.42%
Operating Margin 23.98%
Pretax Margin 24.73%
Profit Margin 19.41%
EBITDA Margin 29.36%
EBIT Margin 23.98%
FCF Margin 21.52%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 3.92%
Shareholder Yield 3.92%
Earnings Yield 3.11%
FCF Yield 3.59%
Dividend Details

Analyst Forecast

The average price target for DexCom is $98.58, which is 20.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target $98.58
Price Target Difference 20.16%
Analyst Consensus Strong Buy
Analyst Count 29
Revenue Growth Forecast (3Y) 11.21%
EPS Growth Forecast (3Y) 20.69%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Jun 13, 2022
Split Type Forward
Split Ratio 4:1

Scores

DexCom has an Altman Z-Score of 6.93 and a Piotroski F-Score of 7.

Altman Z-Score 6.93
Piotroski F-Score 7